Published in Lancet on June 08, 2013
Kyoto global consensus report on Helicobacter pylori gastritis. Gut (2015) 1.47
Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials. Saudi J Gastroenterol (2017) 1.39
Is the AIMS65 score useful in predicting outcomes in peptic ulcer bleeding? World J Gastroenterol (2014) 1.27
Reduced hemoglobin and increased C-reactive protein are associated with upper gastrointestinal bleeding. World J Gastroenterol (2014) 0.93
Perforated peptic ulcer. Lancet (2015) 0.92
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med (2016) 0.92
Diagnosis and treatment of perforated or bleeding peptic ulcers: 2013 WSES position paper. World J Emerg Surg (2014) 0.91
The AIMS65 Score Is a Useful Predictor of Mortality in Patients with Nonvariceal Upper Gastrointestinal Bleeding: Urgent Endoscopy in Patients with High AIMS65 Scores. Clin Endosc (2015) 0.89
Application of cyanoacrylate in difficult-to-arrest acute non-variceal gastrointestinal bleeding. Wideochir Inne Tech Maloinwazyjne (2014) 0.84
Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis. World J Gastroenterol (2014) 0.83
When Should Antiplatelet Agents Be Resumed After Successful Endoscopic Hemostasis in Patients with Peptic Ulcer Bleeding? Dig Dis Sci (2016) 0.81
Upper-gastrointestinal bleeding secondary to peptic ulcer disease: incidence and outcomes. World J Gastroenterol (2014) 0.79
Potential role of probiotics in the management of gastric ulcer. Exp Ther Med (2016) 0.79
Optimal initiation of Helicobacter pylori eradication in patients with peptic ulcer bleeding. World J Gastroenterol (2015) 0.78
Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance. Biomed Res Int (2014) 0.78
Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding. BMC Pharmacol Toxicol (2014) 0.78
Predicting outcomes in patients with perforated gastroduodenal ulcers: artificial neural network modelling indicates a highly complex disease. Eur J Trauma Emerg Surg (2014) 0.77
Upper gastrointestinal bleeding due to peptic ulcer disease is not associated with air pollution: a case-crossover study. BMC Gastroenterol (2015) 0.77
Endoscopic management of refractory gastrointestinal non-variceal bleeding using Histoacryl (N-butyl-2-cyanoacrylate) glue. Gastroenterol Rep (Oxf) (2015) 0.77
Diagnostic accuracy and implementation of computed tomography angiography for gastrointestinal hemorrhage according to clinical severity. Clin Exp Emerg Med (2016) 0.75
Endoscopic management of peptic ulcer bleeding. Clin Endosc (2015) 0.75
Peptic ulcer diseases: genetics, mechanism, and therapies. Biomed Res Int (2014) 0.75
Intraoperative salvage endoscopy performed during orthotopic liver transplantation due to esophageal bleeding. Wideochir Inne Tech Maloinwazyjne (2015) 0.75
Improvement of Short-Term Outcomes for High-Risk Bleeding Peptic Ulcers With Addition of Argon Plasma Coagulation Following Endoscopic Injection Therapy: A Randomized Controlled Trial. Medicine (Baltimore) (2015) 0.75
Immunosuppressive agents are associated with peptic ulcer bleeding. Exp Ther Med (2017) 0.75
Antithrombotic drugs and non-variceal bleeding outcomes and risk scoring systems: comparison of Glasgow Blatchford, Rockall and Charlson scores. Frontline Gastroenterol (2016) 0.75
Hemocoagulase might not control but worsen gastrointestinal bleeding in an elderly patient with type II respiratory failure. Transl Gastroenterol Hepatol (2017) 0.75
Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects. Eur J Clin Pharmacol (2017) 0.75
Outcomes of Propofol Sedation During Emergency Endoscopy Performed for Upper Gastrointestinal Bleeding. Dig Dis Sci (2015) 0.75
Relevance of surgery in patients with non-variceal upper gastrointestinal bleeding. Langenbecks Arch Surg (2017) 0.75
Impact of Gastric H(+)/K(+)-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects. Front Pharmacol (2017) 0.75
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med (2010) 6.36
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol (2011) 5.72
New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology (2013) 4.58
Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med (2007) 4.29
Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med (2009) 4.11
Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med (2009) 3.90
The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med (2003) 3.75
Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 3.66
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology (2013) 3.55
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
Peptic ulcer disease. Lancet (2009) 3.23
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology (2008) 3.18
Competence measurement during colonoscopy training: the use of self-assessment of performance measures. Am J Gastroenterol (2012) 3.17
Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA (2013) 3.15
Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy. Can J Gastroenterol (2012) 3.15
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology (2005) 3.10
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology (2011) 3.08
Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol (2003) 2.86
Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol (2009) 2.73
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized study. Gastrointest Endosc (2007) 2.50
Laparoscopic Heller's myotomy versus pneumatic dilation in the treatment of idiopathic achalasia: a meta-analysis of randomized, controlled trials. Gastrointest Endosc (2013) 2.46
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol (2007) 2.26
Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis (2011) 2.24
Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol (2012) 2.24
Double balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding: an updated meta-analysis. J Gastroenterol Hepatol (2011) 2.24
Chronic gastrointestinal ischaemia: shifting paradigms. Gut (2010) 2.23
Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol (2006) 2.21
Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology (2003) 2.16
Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc (2006) 2.10
Quality evaluation of colonoscopy reporting and colonoscopy performance in daily clinical practice. Gastrointest Endosc (2011) 2.09
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet (2004) 2.06
High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut (2011) 2.06
Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage. Gastrointest Endosc (2010) 2.04
A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis (2010) 1.99
Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis (2011) 1.97
Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc (2009) 1.97
Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus. Clin Gastroenterol Hepatol (2012) 1.96
A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol (2005) 1.94
The yield and the predictors of esophageal pathology when upper endoscopy is used for the initial evaluation of dysphagia. Gastrointest Endosc (2005) 1.93
Cure of Barrett's carcinoma by ifosfamide chemotherapy. Eur J Gastroenterol Hepatol (2002) 1.92
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ (2008) 1.91
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst (2009) 1.89
Capsule endoscopy or angiography in patients with acute overt obscure gastrointestinal bleeding: a prospective randomized study with long-term follow-up. Am J Gastroenterol (2012) 1.88
Differences in proximal serrated polyp detection among endoscopists are associated with variability in withdrawal time. Gastrointest Endosc (2013) 1.87
Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology (2012) 1.87
Transcriptional profiling of Helicobacter pylori Fur- and iron-regulated gene expression. Microbiology (2005) 1.85
Electrocautery therapy for refractory anastomotic strictures of the esophagus. Gastrointest Endosc (2006) 1.76
Ectopic varices. Gastrointest Endosc (2011) 1.75
Single-balloon-assisted colonoscopy in patients with previously failed colonoscopy. Gastrointest Endosc (2010) 1.74
The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol (2010) 1.73
Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg (2010) 1.70
ERCP as an outpatient treatment: a review. Gastrointest Endosc (2008) 1.68
Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut (2010) 1.68
Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol (2006) 1.66
Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. Am J Gastroenterol (2011) 1.66
Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology (2008) 1.66
A randomized comparison of electrocautery incision with Savary bougienage for relief of anastomotic gastroesophageal strictures. Gastrointest Endosc (2009) 1.66
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut (2009) 1.65
FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS One (2013) 1.65
Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease. Sci Transl Med (2014) 1.64
Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc (2004) 1.64
Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening. Value Health (2009) 1.61
Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis (2006) 1.60
Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study. Am J Gastroenterol (2009) 1.60
Comparing the diagnostic yields of technologists and radiologists in an invitational colorectal cancer screening program performed with CT colonography. Radiology (2012) 1.60
Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer. Clin Cancer Res (2011) 1.59
The Global Rating Scale in clinical practice: a comprehensive quality assurance programme for endoscopy departments. Dig Liver Dis (2012) 1.59
Accuracy of narrow-band imaging in predicting colonoscopy surveillance intervals and histology of distal diminutive polyps: results from a multicenter, prospective trial. Gastrointest Endosc (2013) 1.58
Ingestion of acid and alkaline agents: outcome and prognostic value of early upper endoscopy. Gastrointest Endosc (2004) 1.57
Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology (2005) 1.56
Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointest Endosc (2008) 1.56
Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut (2011) 1.56
The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest Endosc (2009) 1.56
Increased risk of advanced neoplasms among asymptomatic siblings of patients with colorectal cancer. Gastroenterology (2012) 1.54
Adenoma detection with cap-assisted colonoscopy versus regular colonoscopy: a randomised controlled trial. Gut (2011) 1.53
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus. Am J Gastroenterol (2008) 1.51
Clinical consequences of videocapsule endoscopy in GI bleeding and Crohn's disease. Gastrointest Endosc (2007) 1.50
The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up. Dis Colon Rectum (2012) 1.49
Small bowel enteropathy associated with chronic low-dose aspirin therapy. Lancet (2007) 1.49
Coumarin-induced intramural hematoma of the duodenum: case report and review of the literature. Scand J Gastroenterol (2010) 1.48
A fully-covered stent (Alimaxx-E) for the palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc (2009) 1.47
Card15 and Crohn's disease: healthy homozygous carriers of the 3020insC frameshift mutation. Am J Gastroenterol (2003) 1.47
The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc (2010) 1.46
The cost of an upper gastroduodenal endoscopy: an activity-based approach. Can J Gastroenterol (2002) 1.46
Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol (2004) 1.46
Breaking the barrier: using extractable fully covered metal stents to treat benign biliary hilar strictures. Gastrointest Endosc (2011) 1.45
Risk of colorectal cancer in patients with Barrett's esophagus: A Dutch population-based study. Am J Gastroenterol (2009) 1.44
Empirical treatment based on "typical" reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection. Gastrointest Endosc (2002) 1.44
Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy. Gastrointest Endosc (2010) 1.43